Dasotraline

Dasotraline
Systematic (IUPAC) name
(1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Identifiers
CAS Number 675126-05-3 YesY
PubChem CID 9947999
ChemSpider 8123611 N
UNII 4D28EY0L5T YesY
ChEMBL CHEMBL3301595
Chemical data
Formula C16H15Cl2N
Molar mass 292.20 g·mol−1
 NYesY (what is this?)  (verify)

Dasotraline (INN)[1] (former developmental code name SEP-225,289) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that is under development by Sunovion for clinical use.[2][3][4][5] The drug is no longer being developed for major depressive disorder (MDD), but is still under investigation for the treatment of attention-deficit hyperactivity disorder (ADHD) and eating disorders.[6]

See also

References

  1. "WHO Drug Information, Vol. 27, No. 4, 2013 Proposed INN: List 110" (PDF). WHO. Retrieved 4 November 2014.
  2. Chen Z, Skolnick P (September 2007). "Triple uptake inhibitors: therapeutic potential in depression and beyond". Expert Opin Investig Drugs 16 (9): 1365–77. doi:10.1517/13543784.16.9.1365. PMID 17714023.
  3. DeLorenzo C, Lichenstein S, Schaefer K, Dunn J, Marshall R, Organisak L, Kharidia J, Robertson B, Mann JJ, Parsey RV (July 2011). "SEP-225289 serotonin and dopamine transporter occupancy: a PET study". J. Nucl. Med. 52 (7): 1150–5. doi:10.2967/jnumed.110.084525. PMC 3856248. PMID 21680689.
  4. Ziegler, L.; Küffer, G.; Euler, E.; Wilhelm, K. (1990). "Arthrographic imaging of ganglions of the hand". RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 153 (2): 143–146. doi:10.1055/s-2008-1033352. PMID 2168068.
  5. Guiard, B. (2009). "P.1.c.059 Electrophysiological properties of the triple reuptake inhibitor SEP 225289 on monoaminergic neurons". European Neuropsychopharmacology 19: S285. doi:10.1016/S0924-977X(09)70419-5.
  6. "Dasotraline Adult ADHD Study". U.S. National Institutes of Health. Retrieved February 13, 2015.

Further reading

Liming Shao Patent
Asymmetry Patent



This article is issued from Wikipedia - version of the Monday, December 14, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.